Baxter PE Ratio 2010-2025 | BAX
Current and historical p/e ratio for Baxter (BAX) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Baxter PE ratio as of May 09, 2025 is 11.84.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Baxter PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-05-09 | 30.90 | 0.00 | |
| 2025-03-31 | 34.23 | $-1.10 | 0.00 |
| 2024-12-31 | 29.02 | $-1.28 | 0.00 |
| 2024-09-30 | 37.59 | $0.20 | 187.97 |
| 2024-06-30 | 32.87 | $4.86 | 6.76 |
| 2024-03-31 | 41.63 | $5.20 | 8.01 |
| 2023-12-31 | 37.39 | $5.22 | 7.16 |
| 2023-09-30 | 36.21 | $5.10 | 7.10 |
| 2023-06-30 | 43.41 | $-5.66 | 0.00 |
| 2023-03-31 | 38.37 | $-4.88 | 0.00 |
| 2022-12-31 | 47.88 | $-4.83 | 0.00 |
| 2022-09-30 | 50.34 | $-4.72 | 0.00 |
| 2022-06-30 | 59.73 | $2.00 | 29.86 |
| 2022-03-31 | 71.82 | $2.09 | 34.36 |
| 2021-12-31 | 79.25 | $2.53 | 31.32 |
| 2021-09-30 | 73.98 | $2.39 | 30.95 |
| 2021-06-30 | 73.78 | $2.19 | 33.69 |
| 2021-03-31 | 77.03 | $2.08 | 37.03 |
| 2020-12-31 | 73.06 | $2.14 | 34.14 |
| 2020-09-30 | 72.99 | $1.76 | 41.47 |
| 2020-06-30 | 77.92 | $1.78 | 43.77 |
| 2020-03-31 | 73.28 | $1.96 | 37.39 |
| 2019-12-31 | 75.28 | $1.98 | 38.02 |
| 2019-09-30 | 78.53 | $2.68 | 29.30 |
| 2019-06-30 | 73.35 | $2.97 | 24.70 |
| 2019-03-31 | 72.61 | $2.94 | 24.70 |
| 2018-12-31 | 58.63 | $2.99 | 19.61 |
| 2018-09-30 | 68.48 | $2.21 | 30.98 |
| 2018-06-30 | 65.42 | $1.66 | 39.41 |
| 2018-03-31 | 57.47 | $1.51 | 38.06 |
| 2017-12-31 | 56.98 | $1.29 | 44.17 |
| 2017-09-30 | 55.18 | $1.86 | 29.67 |
| 2017-06-30 | 53.10 | $1.65 | 32.18 |
| 2017-03-31 | 45.36 | $3.36 | 13.50 |
| 2016-12-31 | 38.69 | $8.99 | 4.30 |
| 2016-09-30 | 41.41 | $8.92 | 4.64 |
| 2016-06-30 | 39.23 | $8.68 | 4.52 |
| 2016-03-31 | 35.53 | $7.09 | 5.01 |
| 2015-12-31 | 32.90 | $1.75 | 18.80 |
| 2015-09-30 | 28.25 | $3.12 | 9.05 |
| 2015-06-30 | 32.56 | $3.98 | 8.18 |
| 2015-03-31 | 31.89 | $4.33 | 7.37 |
| 2014-12-31 | 34.12 | $4.56 | 7.48 |
| 2014-09-30 | 33.42 | $3.41 | 9.80 |
| 2014-06-30 | 33.66 | $3.54 | 9.51 |
| 2014-03-31 | 34.26 | $3.66 | 9.36 |
| 2013-12-31 | 32.38 | $3.65 | 8.87 |
| 2013-09-30 | 30.59 | $3.95 | 7.74 |
| 2013-06-30 | 32.25 | $4.02 | 8.02 |
| 2013-03-31 | 33.82 | $4.14 | 8.17 |
| 2012-12-31 | 31.04 | $4.18 | 7.43 |
| 2012-09-30 | 28.06 | $4.11 | 6.83 |
| 2012-06-30 | 24.75 | $4.06 | 6.10 |
| 2012-03-31 | 27.83 | $3.94 | 7.06 |
| 2011-12-31 | 23.04 | $3.88 | 5.94 |
| 2011-09-30 | 26.14 | $3.78 | 6.92 |
| 2011-06-30 | 27.79 | $3.78 | 7.35 |
| 2011-03-31 | 25.04 | $3.61 | 6.94 |
| 2010-12-31 | 23.57 | $3.49 | 6.75 |
| 2010-09-30 | 22.21 | $3.71 | 5.99 |
| 2010-06-30 | 18.92 | $3.57 | 5.30 |
| 2010-03-31 | 27.10 | $3.63 | 7.47 |
| 2009-12-31 | 27.32 | $3.60 | 7.59 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.857B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $231.816B | 27.87 |
| Boston Scientific (BSX) | United States | $152.176B | 38.10 |
| Stryker (SYK) | United States | $145.393B | 30.40 |
| EssilorLuxottica (ESLOY) | France | $127.544B | 0.00 |
| Medtronic (MDT) | Ireland | $107.067B | 15.63 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.941B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.416B | 27.54 |
| ResMed (RMD) | United States | $35.930B | 26.99 |
| GE HealthCare Technologies (GEHC) | United States | $31.992B | 15.19 |
| Agilent Technologies (A) | United States | $30.486B | 20.14 |
| Terumo (TRUMY) | Japan | $28.205B | 0.00 |
| Koninklijke Philips (PHG) | Netherlands | $23.066B | 16.58 |
| Insulet (PODD) | United States | $21.859B | 85.82 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.837B | 12.10 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.412B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.030B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.686B | 22.60 |
| Lantheus Holdings (LNTH) | United States | $5.655B | 14.27 |
| Prestige Consumer Healthcare (PBH) | United States | $4.325B | 19.27 |
| Perrigo (PRGO) | Ireland | $3.713B | 9.41 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.426B | 14.92 |
| ICU Medical (ICUI) | United States | $3.404B | 25.10 |
| Envista Holdings (NVST) | United States | $2.981B | 24.77 |
| QuidelOrtho (QDEL) | United States | $2.458B | 16.90 |
| GN Store Nord (GNNDY) | Denmark | $2.075B | 17.18 |
| LeMaitre Vascular (LMAT) | United States | $1.813B | 40.53 |
| AtriCure (ATRC) | United States | $1.534B | 0.00 |
| Neogen (NEOG) | United States | $1.296B | 16.58 |
| Green Thumb Industries (GTBIF) | United States | $1.173B | 26.38 |
| Kestra Medical Technologies (KMTS) | United States | $1.164B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.156B | 11.75 |
| BioLife Solutions (BLFS) | United States | $1.106B | 0.00 |
| InMode (INMD) | Israel | $1.005B | 9.20 |
| Phibro Animal Health (PAHC) | United States | $0.910B | 11.64 |
| Evolus (EOLS) | United States | $0.632B | 0.00 |
| CeriBell (CBLL) | United States | $0.577B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.557B | 0.00 |
| Owens & Minor (OMI) | United States | $0.542B | 4.49 |
| Valneva SE (VALN) | France | $0.541B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.504B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.383B | 0.00 |
| Omeros (OMER) | United States | $0.360B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.339B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.290B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.288B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.283B | 10.42 |
| Aurora Cannabis (ACB) | Canada | $0.273B | 48.50 |
| Sanuwave Health (SNWV) | United States | $0.258B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.250B | 21.07 |
| Verano Holdings (VRNOF) | United States | $0.248B | 0.00 |
| Cerus (CERS) | United States | $0.247B | 0.00 |
| ZimVie (ZIMV) | United States | $0.244B | 11.09 |
| Canopy Growth (CGC) | Canada | $0.241B | 0.00 |
| Biote (BTMD) | United States | $0.219B | 6.15 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| High Tide (HITI) | Canada | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.18 |
| Brainsway (BWAY) | Israel | $0.164B | 51.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.162B | 0.00 |
| Organigram Global (OGI) | Canada | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.147B | 18.16 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.103B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.094B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| MacroGenics (MGNX) | United States | $0.090B | 0.00 |
| Agape ATP (ATPC) | $0.078B | 0.00 | |
| Fonar (FONR) | United States | $0.077B | 10.77 |
| Veru (VERU) | United States | $0.074B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| United Health Products (UEEC) | United States | $0.059B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.055B | 0.00 |
| ImmuCell (ICCC) | United States | $0.046B | 0.00 |
| Apyx Medical (APYX) | United States | $0.044B | 0.00 |
| Modular Medical (MODD) | United States | $0.041B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.038B | 56.00 |
| United-Guardian (UG) | United States | $0.037B | 12.79 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |